id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-3962-0001,FDA,FDA-2026-N-3962,"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—
United States (U.S.) 2026–2027 Formula for COVID–19 Vaccine Composition",Notice,Request for Comments,2026-04-27T04:00:00Z,2026,4,2026-04-27T04:00:00Z,2026-05-28T03:59:59Z,2026-05-16T09:00:16Z,2026-08122,1,0,09000064b92ad21d